Skip to main content
SpringerLink
Log in

The Economics of Rectal Cancer Care: Considerations in Interpretation of the Literature

  • Chapter
  • First Online:
Comprehensive Rectal Cancer Care

  • 602 Accesses

Abstract

This chapter provides a general overview of considerations when economic analyses are reported for the management of patients with rectal cancer. Although we have included an assessment of selected European, Australasian and North American variations in reported series as they pertain to rectal cancer for the use of radiotherapy, adjuvant-neoadjuvant chemotherapy and multimodality therapy, we describe more the pitfalls in the interpretation of comparative economic data assessing rectal cancer care.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lipscomb J, Yabroff KR, Hornbrook MC, Gigli A, Francisi S, Krahn M, Gatta G, Trama A, Ritwoller DP, Durand-Zaleski I, Salloum R, Chawla N, Angiolini C, Crocetti E, Giusti F, Guzzinati S, Mezzetti M, Miccinesi G, Mariotto A. Comparing cancer care, outcomes, and costs across health systems: charting the course. JNCI Monogr. 2013;46:124–30.

    Article  Google Scholar 

  2. International Agency for Research in Cancer and International Association of Cancer Registries. Cancer incidence in five continents, vol. IX, IARC scientific publication no. 160. Lyon: IARC; 2007.

    Google Scholar 

  3. EUROCARE. Survival of cancer patients in Europe. http://www.eurocare.it

  4. Organization for Economic Cooperation and Development. Health expenditure. In: OECD factbook 2011–2012: economic, environmental and social statistics. http://www.oecd.org/publications/oecd-factbook-18147364.htm.

  5. Gigli A, Warren JL, Yabroff KR, et al. Initial treatment of newly diagnosed elderly colorectal cancer patients: patterns of care in Italy and the United States. J Natl Cancer Inst Monogr. 2013;46(1):88–98.

    Article  Google Scholar 

  6. Gatta G, Trama A, Capocaccia R. Variations in cancer survival and patterns of care across Europe: roles of wealth and health-care organization. J Natl Cancer Inst Monogr. 2013;46(1):79–87.

    Article  Google Scholar 

  7. Chawla N, Butler EN, Lund J, Warren JL, Harlan LC, Yabroff KR. Patterns of colorectal cancer care in Europe, Australia, and New Zealand. J Natl Cancer Inst Monogr. 2013;46(1):36–61.

    Article  Google Scholar 

  8. Butler EN, Chawla N, Lund J, Harlan LC, Warren JL, Yabroff KR. Patterns of colorectal cancer care in the United States and Canada: a systematic review. J Natl Cancer Inst Monogr. 2013;46(1):13–35.

    Article  Google Scholar 

  9. Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.

    Article  CAS  Google Scholar 

  10. Sullivan R, Peppercorn J, Sikora K, et al. Delivering affordable cancer care in high-income countries. Lancet Oncol. 2011;12(10):933–80.

    Article  Google Scholar 

  11. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010–2020. J Natl Cancer Inst. 2011;103(2):117–28.

    Article  Google Scholar 

  12. Bach PB. Limits on Medicare’s ability to control rising spending on cancer drugs. Erratum in N Engl J Med. 2009:26;360(9):944. Off PubMed N Engl J Med. 2009:5;360(6):626–33. https://doi.org/10.1056/NEJMhpr0807774.

    Article  CAS  Google Scholar 

  13. Medicare Part B drugs and oncology: statement of Mark E. 3. Miller before the Subcommittee on Health, Committee on Ways and Means, U.S. House of Representatives; 2006 Jul 13. http://www.medpac.gov/publications/congressional_testimony/071306_Testimony_Part%20B_oncology.pdf. Accessed 16 Jan 2009.

  14. Medicare expenditures from the Office of the Actuary. Baltimore: Centers for Medicare & Medicaid Services. http://www.cms.hhs.gov/NationalHealthExpendData/downloads/tables.pdf. Accessed 16 Jan 2009.

  15. Zheng Z, Han X, Guy GP Jr, Davidoff AJ, Li C, Banegas MP, Ekwueme DU, Yabroff KR, Jemal A. Do cancer survivors change their prescription drug use for financial reasons? Findings from a nationally representative sample in the United States. Cancer. 2017;123(8):1453–63.

    Article  Google Scholar 

  16. Schrag D. The price tag on progress—chemotherapy for colorectal cancer. N Engl J Med. 2004;351:317–9.

    Article  CAS  Google Scholar 

  17. Yabroff KR, Francisi S, Mariotto A, Mezzetti M, Gigli A, Lipscomb J. Advancing comparative studies of patterns of care and economic outcomes in cancer: challenges and opportunities. JNCI Monogr. 2013;46:1–6.

    Article  Google Scholar 

  18. OECD Health Data 2012. Organisation for Economic Co-operation and Development (OECD) Website. http://www.oecd.org/health/health-systems/oecdhealthdata2012.htm. Accessed 3 Jan 2013.

  19. Fuchs VR. How and why US health care differs from that in other OECD countries. JAMA. 2013;309(1):33–4.

    Article  CAS  Google Scholar 

  20. Denost Q, Saillour F, Masya L, Martinaud HM, Guillon S, Kret M, Rullier E, Quintard B, Solomon M. Benchmarking trial between France and Australia comparing management of primary rectal cancer beyond TME and locally recurrent rectal cancer (PelviCare Trial): rationale and design. BMC Cancer. 2016;16:262. https://doi.org/10.1186/s12885-016-2286-1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Yabroff KR, Borowski L, Lipscomb J. Economic studies in colorectal cancer: challenges in measuring and comparing costs. J Natl Cancer Inst Monogr. 2013;46(1):62–78.

    Article  Google Scholar 

  22. Elferink MA, van Steenbergen LN, Krijnen P, et al., Working Group Output of the Netherlands Cancer Registry. Marked improvements in survival of patients with rectal cancer in the Netherlands following changes in therapy, 1989–2006. Eur J Cancer. 2010;46(8):1421–9.

    Article  CAS  Google Scholar 

  23. Khani MH, Smedh K. Centralization of rectal cancer surgery improves long-term survival. Color Dis. 2010;12(9):874–9.

    Article  Google Scholar 

  24. Marwan K, Staples MP, Thursfield V, Bell SW. The rate of abdomino-perineal resections for rectal cancer in the state of Victoria, Australia: a population-based study. Dis Colon Rectum. 2010;53(12):1645–51.

    Article  CAS  Google Scholar 

  25. Raine R, Wong W, Scholes S, Ashton C, Obichere A, Ambler G. Social variations in access to hospital care for patients with colorectal, breast, and lung cancer between 1999 and 2006: retrospective analysis of hospital episode statistics. BMJ. 2010;340:b5479. https://doi.org/10.1136/bmj.b5479.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Martling A, Granath F, Cedermark B, Johansson R, Holm T. Gender differences in the treatment of rectal cancer: a population based study. Eur J Surg Oncol. 2009;35(4):427–33.

    Article  CAS  Google Scholar 

  27. Sigurdsson HK, Søreide JA, Dahl O, Skarstein A, Von Hofacker S, Kørner H. Utilisation of specialist care in patients with incurable rectal cancer. A population-based study from Western Norway. Acta Oncol. 2009;48(3):377–84.

    Article  Google Scholar 

  28. Tilney HS, Heriot AG, Purkayastha S, et al. A national perspective on the decline of abdominoperineal resection for rectal cancer. Ann Surg. 2008;247(1):77–84.

    Article  Google Scholar 

  29. Ptok H, Marusch F, Kuhn R, Gastinger I, Lippert H. Influence of hospital volume on the frequency of abdominoperineal resection and long-term oncological outcomes in low rectal cancer. Eur J Surg Oncol. 2007;33(7):854–61.

    Article  CAS  Google Scholar 

  30. Phelip JM, Milan C, Herbert C, et al. Evaluation of the management of rectal cancers before and after the consensus conference in France. Eur J Gastroenterol Hepatol. 2004;16(10):1003–9.

    Article  Google Scholar 

  31. Wibe A, Syse A, Andersen E, Tretli S, Myrvold HE, Søreide O, Norwegian Rectal Cancer Group. Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection. Dis Colon Rectum. 2004;47(1):48–58.

    Article  Google Scholar 

  32. Engel AF, Oomen JL, Eijsbouts QA, Cuesta MA, van de Velde CJ. Nationwide decline in annual numbers of abdomino-perineal resections: effect of a successful national trial? Color Dis. 2003;5(2):180–4.

    Google Scholar 

  33. Farmer KC, Penfold C, Millar JL, et al., Gastrointestinal Committee of the Victorian Cooperative Oncology Group, The Cancer Council of Victoria. Rectal cancer in Victoria in 1994: patterns of reported management. ANZ J Surg. 2002;72(4):265–70.

    Article  Google Scholar 

  34. García-Granero E, Martí-Obiol R, Gómez-Barbadillo J, et al. Impact of surgeon organization and specialization in rectal cancer outcome. Color Dis. 2001;3(3):179–84.

    Article  Google Scholar 

  35. Young JM, Leong DC, Armstrong K, et al. Concordance with national guidelines for colorectal cancer care in New South Wales: a population- based patterns of care study. Med J Aust. 2007;186(6):292–5.

    PubMed  Google Scholar 

  36. Lemmens VE, Verheij CD, Janssen-Heijnen ML, Rutten HJ, Coebergh JW, Gastro-Intestinal Cancer Study Group Comprehensive Cancer Centre South IKZ. Mixed adherence to clinical practice guidelines for colorectal cancer in the Southern Netherlands in 2002. Eur J Surg Oncol. 2006;32(2):168–73.

    Article  CAS  Google Scholar 

  37. Hall SE, Holman CD, Platell C, Sheiner H, Threlfall T, Semmens J. Colorectal cancer surgical care and survival: do private health insurance, socioeconomic and locational status make a difference? ANZ J Surg. 2005;75(11):929–35.

    Article  Google Scholar 

  38. Jestin P, Heurgren M, Påhlman L, Glimelius B, Gunnarsson U. Elective surgery for colorectal cancer in a defined Swedish population. Eur J Surg Oncol. 2004;30(1):26–33.

    Article  CAS  Google Scholar 

  39. Chiappa A, Zbar AP, Bertani E, Biella F, Audisio RA, Staudacher C. Surgical outcomes for colorectal cancer patients including the elderly. Hepato-Gastroenterology. 2001;48(38):440–4.

    CAS  PubMed  Google Scholar 

  40. Pisu M, Richardson LC, Kim YI, et al. Less-than-standard treatment in rectal cancer patients: which patients are at risk [published online ahead of print April 2, 2010]? J Natl Med Assoc. 2010;102(3):190–8.

    Article  Google Scholar 

  41. Latosinsky S, Turner D. Local recurrence after rectal cancer treatment in Manitoba [published online ahead of print February 2, 2009]. Can J Surg. 2009;52(1):45–50.

    PubMed  PubMed Central  Google Scholar 

  42. Chang GJ, Skibber JM, Feig BW, Rodriguez-Bigas M. Are we under- treating rectal cancer in the elderly? An epidemiologic study. Ann Surg. 2007;246(2):215–21.

    Article  Google Scholar 

  43. Ricciardi R, Virnig BA, Madoff RD, Rothenberger DA, Baxter NN. The status of radical proctectomy and sphincter-sparing surgery in the United States. Dis Colon Rectum. 2007;50(8):1119–27, discussion 1126–1127.

    Article  Google Scholar 

  44. Phang PT, MacFarlane JK, Taylor RH, et al. Practice patterns and appropriateness of rectal cancer management in British Columbia. BC Med J. 2003;45(7):324–9.

    Google Scholar 

  45. Schroen AT, Cress RD. Use of surgical procedures and adjuvant therapy in rectal cancer treatment: a population-based study [published online ahead of print October 31, 2001]. Ann Surg. 2001;234(5):641–51.

    Article  CAS  Google Scholar 

  46. Marusch F, Koch A, Schmidt U, Pross M, Gastinger I, Lippert H. Hospital caseload and the results achieved in patients with rectal cancer. Br J Surg. 2001;88(10):1397–402.

    Article  CAS  Google Scholar 

  47. Lemmens VE, Janssen-Heijnen ML, Verheij CD, Houterman S, Repelaer van Driel OJ, Coebergh JW. Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer. Br J Surg. 2005;92(5):615–23.

    Article  CAS  Google Scholar 

  48. Gatta G, Zigon G, Aareleid T, et al. Patterns of care for European colorectal cancer patients diagnosed 1996–1998: a EUROCARE high resolution study. Acta Oncol. 2010;49(6):776–83.

    Article  Google Scholar 

  49. Vulto JC, Lybeert ML, Louwman MW, Poortmans PM, Coebergh JW. Population-based study of trends and variations in radiotherapy as part of primary treatment of cancer in the southern Netherlands between 1988 and 2006, with an emphasis on breast and rectal cancer. Int J Radiat Oncol Biol Phys. 2009;74(2):464–71.

    Article  Google Scholar 

  50. Hansen MH, Kjaeve J, Revhaug A, Eriksen MT, Wibe A, Vonen B, Norwegian Rectal Cancer Group. Impact of radiotherapy on local recurrence of rectal cancer in Norway. Br J Surg. 2007;94(1):113–8.

    Article  CAS  Google Scholar 

  51. Ng VV, Tytherleigh MG, Fowler L, Farouk R. Subspecialisation and its effect on the management of rectal cancer. Ann R Coll Surg Engl. 2006;88(2):181–4.

    Article  Google Scholar 

  52. Birbeck KF, Macklin CP, Tiffin NJ, et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg. 2002;235(4):449–57.

    Article  Google Scholar 

  53. Faivre-Finn C, Benhamiche AM, Maingon P, Janoray P, Faivre J. Changes in the practice of adjuvant radiotherapy in resectable rectal cancer within a French well-defined population. Radiother Oncol. 2000;57(2):137–42.

    Article  CAS  Google Scholar 

  54. Carsin AE, Sharp L, Cronin-Fenton DP, Céilleachair AO, Comber H. Inequity in colorectal cancer treatment and outcomes: a population-based study [published online ahead of print July 1, 2008]. Br J Cancer. 2008;99(2):266–74.

    Article  CAS  Google Scholar 

  55. Coriat R, Mahboubi A, Lejeune C, Bouvier AM, Bedenne L, Bonithon-Kopp C. How do gastroenterologists follow patients with colorectal cancer after curative surgical resection? A three-year population-based study. Gastroenterol Clin Biol. 2007;31(11):950–5.

    Article  Google Scholar 

  56. McGrath DR, Leong DC, Armstrong BK, Spigelman AD. Management of colorectal cancer patients in Australia: the National Colorectal Cancer Care Survey. ANZ J Surg. 2004;74(1–2):55–64.

    Article  Google Scholar 

  57. Kuo I, Wong JH, Roy-Chowdhury S, Lum SS, Morgan JW, Kazanjian K. The use of pelvic radiation in stage II rectal cancer: a population-based analysis [published online ahead of print October 26, 2010]. Am Surg. 2010;76(10):1092–5.

    PubMed  Google Scholar 

  58. Lin C, Charlton ME, Meza JL, Enke CA, Loberiza FR Jr. Temporal and regional variations in the use of preoperative radiation therapy for rectal cancer. Am J Clin Oncol. 2010;33(5):443–7.

    Article  Google Scholar 

  59. Demers AA, Latosinsky S, Turner D. Survival and treatment trends of rectal cancer patients in a population with suboptimal local control. Eur J Surg Oncol. 2008;34(6):655–61.

    Article  CAS  Google Scholar 

  60. Dobie SA, Warren JL, Matthews B, Schwartz D, Baldwin LM, Billingsley K. Survival benefits and trends in use of adjuvant therapy among elderly stage II and III rectal cancer patients in the general population. Cancer. 2008;112(4):789–99.

    Article  Google Scholar 

  61. Baxter NN, Rothenberger DA, Morris AM, Bullard KM. Adjuvant radiation for rectal cancer: do we measure up to the standard of care? An epidemiologic analysis of trends over 25 years in the United States. Dis Colon Rectum. 2005;48(1):9–15.

    Article  CAS  Google Scholar 

  62. Påhlman L, Glimelius B. Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma: report from a randomized multicenter trial. Ann Surg. 1990;211:187–95.

    Article  Google Scholar 

  63. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638–46.

    Article  CAS  Google Scholar 

  64. Martijn H, Vulto JC. Should radiotherapy be avoided or delivered differently in elderly patients with rectal cancer? Eur J Cancer. 2007;43:2301–6.

    Article  CAS  Google Scholar 

  65. Rutten H, Dulk M, Lemmens V, et al. Survival of elderly rectal cancer patients not improved: analysis of population based data on the impact of TME surgery. Eur J Cancer. 2007;43:2295–300.

    Article  Google Scholar 

  66. Rutten HJ, den Dulk M, Lemmens VE, van de Velde CJ, Marijnen CA. Controversies of total mesorectal excision for rectal cancer in elderly patients. Lancet Oncol. 2008;9:494–501.

    Google Scholar 

  67. Damianovich D, Adena M, Tebbutt NC. Treatment of 5-fluorouracil refractory metastatic colorectal cancer: an Australian population-based analysis. Br J Cancer. 2007;96(4):546–50.

    Article  CAS  Google Scholar 

  68. Robinson B, Frizelle F, Dickson M, Frampton C. Colorectal cancer treated at Christchurch Hospital, New Zealand: a comparison of 1993 and 1998 cohorts. N Z Med J. 2005;118(1210):U1323.

    PubMed  Google Scholar 

  69. Romanus D, Weiser MR, Skibber JM, et al. Concordance with NCCN colorectal cancer guidelines and ASCO/NCCN quality measures: an NCCN institutional analysis [published online ahead of print September 17, 2009]. J Natl Compr Cancer Netw. 2009;7(8):895–904.

    Article  Google Scholar 

  70. Pitchforth E, Russell E, Van der Pol M. Access to specialist cancer care: is it equitable? Br J Cancer. 2002;87(11):1221–6.

    Article  CAS  Google Scholar 

  71. Drug Utilization Review Team in Oncology. Adjuvant systemic therapies in patients with colorectal cancer: an audit on clinical practice in Italy. Tumori. 2005;91(6):472–6.

    Google Scholar 

  72. Lemmens VE, van Halteren AH, Janssen-Heijnen ML, Vreugdenhil G, Repelaer van Driel OJ, Coebergh JW. Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity. Ann Oncol. 2005;16(5):767–72.

    Article  CAS  Google Scholar 

  73. Alter E, Phelip JM, Guilhot JN, Matysiak M, Vermorel M, Roblin X. Adjuvant chemotherapy for stage II colon cancer: influence of care structures’ characteristics on a controversial clinical practice. Eur J Gastroenterol Hepatol. 2007;19(11):995–1001.

    Article  Google Scholar 

  74. Kube R, Ptok H, Wolff S, Lippert H, Gastinger I, Study Group Colon/Rectum Carcinoma (Primary Tumour). Quality of medical care in colorectal cancer in Germany. Onkologie. 2009;32(1–2):25–9.

    PubMed  Google Scholar 

  75. Cronin DP, Harlan LC, Potosky AL, Clegg LX, Stevens JL, Mooney MM. Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer. Am J Gastroenterol. 2006;101(10):2308–18.

    Article  CAS  Google Scholar 

  76. Baldwin LM, Dobie SA, Billingsley K, et al. Explaining black-white differences in receipt of recommended colon cancer treatment. J Natl Cancer Inst. 2005;97(16):1211–20.

    Article  Google Scholar 

  77. Morris AM, Billingsley KG, Hayanga AJ, Matthews B, Baldwin LM, Birkmeyer JD. Residual treatment disparities after oncology referral for rectal cancer. J Natl Cancer Inst. 2008;100(10):738–44.

    Article  Google Scholar 

  78. Francisi S, Guzzinati S, Mezzetti M, Crocetti E, Giusti F, Miccinesi G, Paci E, Angiolini C, Gigli A. Cost profiles of colorectal cancer patients in Italy based on individual patterns of care. BMC. 2013;13:329.

    Google Scholar 

  79. Brown ML, Riley GF, Potosky AL, Etzioni RD. Obtaining long-term disease-specific costs of case application to Medicare enrollees diagnosed with colorectal cancer. Med Care. 1999;37:1249–59.

    Article  CAS  Google Scholar 

  80. Klemp M, Fronsdal KB, Facey K. What principles should govern the use of managed entry agreements? Int J Technol Assess. 2011;27:77–83.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery and Transplantation, Department of Surgery B, Chaim Sheba Medical Center, Tel Hashomer Hospital, Ramat Gan, Israel

    Andrew P. Zbar

  2. Department of Anatomy and Neuroscience, The University of Melbourne, Parkville, VIC, Australia

    Andrew P. Zbar

  3. Department of Surgery and Transplantation, Chaim Sheba Medical Center, Ramat Gan, Israel

    Nir Horesh

Authors
  1. Andrew P. Zbar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nir Horesh
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of California, Los Angeles, Los Angeles, CA, USA

    Mary Kwaan

  2. University of Melbourne, Victoria, VIC, Australia

    Andrew Zbar

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Zbar, A.P., Horesh, N. (2019). The Economics of Rectal Cancer Care: Considerations in Interpretation of the Literature. In: Kwaan, M., Zbar, A. (eds) Comprehensive Rectal Cancer Care. Springer, Cham. https://doi.org/10.1007/978-3-319-98902-0_32

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-98902-0_32

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-98901-3

  • Online ISBN: 978-3-319-98902-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation